CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

机译：卡培他滨联合镭223（Xofigo™）在患有BoNe转移灶（CARBON）的乳腺癌患者中：IB / IIA期随机对照试验的研究方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version of this article (10.1186/s13063-019-3643-6) contains supplementary material, which is available to authorized users.

机译：本文的在线版本（10.1186 / s13063-019-3643-6）包含补充材料，可供授权用户使用。

著录项

期刊名称 Current Controlled Trials in Cardiovascular Medicine
作者
Rob Coleman; Janet Brown; Emma Rathbone; Louise Flanagan; Amber Reid; Jessica Kendall; Sacha Howell; Chris Twelves; Carlo Palmieri; Anjana Anand; Iain MacPherson; Sarah Brown;
展开▼
作者单位

展开▼
年(卷),期 2020(21),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Radium-223; Capecitabine; Bone metastases; Bone turnover markers; Breast cancer;

机译：Radium-223;Capecitabine;骨转移;骨转换标志物;乳腺癌;

相似文献

外文文献
中文文献
专利

1. CApecitabine plus Radium-223 (Xofigo?) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial [J] . Rob Coleman, Janet Brown, Emma Rathbone, Trials . 2020,第1期

机译：Capecitabine Plus乳腺癌患者乳腺癌患者（碳）：IA型IIA的研究方案，用于乳腺转移患者（碳）：IA型随机对照试验
2. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial [J] . Smith Matthew, Parker Chris, Saad Fred, The lancet oncology . 2019,第3期

机译：在抗阉割的前列腺癌和骨转移患者中添加镭-223至Abiraatorone醋酸盐和泼尼松或泼尼松龙（ERA 223）：A随机，双盲，安慰剂控制，第3期试验
3. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 20, pg 408, 2019) [J] . Smith M., Parker C., Saad F. The lancet oncology . 2019,第10期

机译：在抗阉割前列腺癌和骨转移患者中添加镭的醋酸盐和泼尼松或泼尼松酮（ERA 223）：随机，双盲，安慰剂控制，第3期试验（Vol 20，PG 408,2019 的）
4. Cluster Randomised Controlled Trial of a Mobile Monitoring and Feedback Tool Embedded in a Counselling Protocol to Stimulate Physical Activity in Chronically Ill Patients Study protocol of the It's LiFe! RCT [C] . Sanne van der Weegen, Huibert Tange, Trudy van der Weijden, International Conference on eHealth, Telemedicine, and Social Medicine . 2015

机译：集群随机对照试验的移动监测和反馈工具嵌入辅导议定书中，以刺激其生命的慢性病患者的体育活动！ RCT.
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS) [O] . Sébastien Thureau, Vincent Marchesi, Marie-Hélène Vieillard, 2021

机译：颅外型体内放射治疗（SBRT）的疗效在患有固体肿瘤（乳腺前列腺和非小细胞肺癌）的标准治疗中最多3个骨转移：随机期III试验的研究方案（立体声-os）
7. CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial [O] . Rob Coleman, Janet Brown, Emma Rathbone, 2020

机译：Capecitabine Plus Radium-223（Xofigo™）在乳腺癌患者骨转移（碳）：IA / IIa随机对照试验的研究方案

CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅